Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory study

IntroductionBreast cancer patients, undergoing low-dose bone-modifying agent (LD-BMA) therapy for cancer treatment-induced bone loss (CTIBL), represent an emerging category at risk of Medication-Related (MRONJ) low (<1%) but not absent. However, data on their oral health status and quality of...

全面介绍

书目详细资料

发表在:	Frontiers in Oral Health
Main Authors:	Rodolfo Mauceri, Martina Coppini, Sara Maria Marchese, Nicola Mauceri, Rita Coniglio, Marco Nisi, Maria Elena Mauceri, Vittorio Fusco, Maria Rosaria Valerio, Giuseppina Campisi
格式:	文件
语言:	英语
出版:	Frontiers Media S.A. 2025-10-01
主题:	osteonecrosis of the jaw ONJ MRONJ breast cancer cancer treatment-induced bone loss CTIBL
在线阅读:	https://www.frontiersin.org/articles/10.3389/froh.2025.1683722/full